Patrick J. McEnany

Companies

• Catalyst PharmaceuticalsBoard member Oct 23, 2006 to now¹
• Catalyst PharmaceuticalsChief executive officer Oct 23, 2006 to Dec 29, 2023¹
• Catalyst PharmaceuticalsPresident Oct 23, 2006 to Dec 29, 2023¹
• Catalyst PharmaceuticalsChair Jan 28, 2008 to Dec 12, 2023²
• ThermoGenesis Holdings, Inc.Board member Jul 12, 2006 to Jul 2, 2014³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Catalyst Pharmaceuticals CPRX0 shares⁴Jul 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 15, 2026Returned to company 4,171,559 shares at $31.50 of Catalyst Pharmaceuticals⁴
• Dec 29, 2025Shares withheld for tax 6,786 shares of Catalyst Pharmaceuticals⁵
• Dec 29, 2025Exercised options 26,334 shares of Catalyst Pharmaceuticals⁵
• Dec 8, 2025Exercised options 3,534 shares of Catalyst Pharmaceuticals⁶
• Dec 1, 2025Gift 45,000 shares of Catalyst Pharmaceuticals⁷
• Dec 1, 2025Gift 45,000 shares of Catalyst Pharmaceuticals⁷
• Dec 1, 2025Gift 45,000 shares of Catalyst Pharmaceuticals⁷
• Nov 21, 2025Exercised options 1,775 shares of Catalyst Pharmaceuticals⁸
• Jun 9, 2025Sold 171,748 shares at $26.11 of Catalyst Pharmaceuticals⁹
• Jun 6, 2025Sold 28,252 shares at $25.95 of Catalyst Pharmaceuticals⁹
• Dec 9, 2024Exercised options 3,533 shares of Catalyst Pharmaceuticals¹⁰
• Nov 20, 2024Sold 72,500 shares at $21.29 of Catalyst Pharmaceuticals¹¹
• Nov 20, 2024Exercised options 72,500 shares at $3.54 of Catalyst Pharmaceuticals¹¹
• Nov 19, 2024Sold 98,345 shares at $21.19 of Catalyst Pharmaceuticals¹¹
• Nov 19, 2024Exercised options 98,345 shares at $3.54 of Catalyst Pharmaceuticals¹¹
• Nov 14, 2024Sold 44,655 shares at $21.75 of Catalyst Pharmaceuticals¹²
• Nov 14, 2024Exercised options 44,655 shares at $3.54 of Catalyst Pharmaceuticals¹²
• Nov 13, 2024Sold 92,500 shares at $22.98 of Catalyst Pharmaceuticals¹²
• Nov 13, 2024Exercised options 92,500 shares at $3.54 of Catalyst Pharmaceuticals¹²
• Nov 12, 2024Sold 192,000 shares at $23.20 of Catalyst Pharmaceuticals¹³
• Nov 12, 2024Exercised options 192,000 shares at $3.54 of Catalyst Pharmaceuticals¹³
• Nov 12, 2024Sold 70,000 shares at $23.42 of Catalyst Pharmaceuticals¹³
• Nov 12, 2024Exercised options 70,000 shares at $4.01 of Catalyst Pharmaceuticals¹³
• Nov 11, 2024Sold 230,000 shares at $23.55 of Catalyst Pharmaceuticals¹³
• Nov 11, 2024Exercised options 230,000 shares at $4.01 of Catalyst Pharmaceuticals¹³